Pennsylvania Senate Panel Blocks Recreational Marijuana Proposal
A proposal to legalize recreational marijuana in Pennsylvania, supported by Democrats, was recently blocked by the Senate Law and Justice Committee. The bill, which aimed to allow adults to purchase c...
FDA Commissioner's Endorsement Accelerates Psychedelic Therapeutics Development
Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) has highlighted the significance of recent comments by FDA Commissioner Dr. Martin Makary, which endorse the accelerated development of psychedelic therape...
U.S. Supreme Court Ruling on CBD Case Could Reshape Cannabis Industry Standards
The U.S. Supreme Court's narrow 5-4 decision in favor of Douglas Horn, a commercial truck driver who sued three CBD companies under the federal RICO statute, underscores the growing legal complexities...
Republican Lawmakers Advocate for Psychedelic Therapies for Veterans Amid Growing Industry Support
Rep. Morgan Luttrell (R-Texas), a retired Navy SEAL, is at the forefront of a growing number of Republican lawmakers advocating for the therapeutic use of psychedelics to treat conditions such as PTSD...
Silo Pharma Secures $2 Million in Public Offering to Advance Psychedelic and CNS Therapeutics
Silo Pharma, a developmental-stage biopharmaceutical company, has successfully closed a public offering raising approximately $2 million. This financial milestone is earmarked for advancing the compan...
Florida's Recreational Cannabis Legalization Faces Legal Hurdles
The path to legalizing recreational cannabis in Florida through a constitutional amendment has encountered significant resistance due to a newly enacted state law that imposes substantial barriers on ...
Silo Pharma Announces Public Offering to Fund Psychedelic and Cannabis Research
Silo Pharma (NASDAQ: SILO) has recently announced a public offering of approximately 3.33 million shares of common stock, along with Series A-1 and Series A-2 warrants, each priced at $0.60 per unit. ...
NRx Pharmaceuticals Reports Narrowed Q1 Losses and Advances in Ketamine and Bipolar Depression Treatments
NRx Pharmaceuticals (NASDAQ: NRXP) has reported a net loss of $5.5 million for Q1 2025, marking an improvement from the $6.5 million loss recorded in the same period the previous year. The company's o...
Unpaid Invoices Threaten Stability in the Cannabis Industry
The cannabis industry is currently facing a significant financial crisis that could have far-reaching implications for businesses across the supply chain. At the heart of this issue is the alarming in...
Leafwire Media and CannaSpyglass Forge Strategic Partnership to Elevate Cannabis Industry Intelligence
Leafwire Media, the leading B2B networking platform for the cannabis, hemp, and psychedelics industries, and CannaSpyglass, a premier cannabis data and market intelligence provider, today announced a ...
Cybin Partners with Thermo Fisher Scientific to Advance CYB003 for Major Depressive Disorder
Cybin Inc., a clinical-stage biopharmaceutical company, has announced a strategic partnership with Thermo Fisher Scientific to support the Phase 3 clinical supply and potential commercial manufacturin...
Silo Pharma Partners with Veloxity Labs for PTSD Treatment Study
Silo Pharma (NASDAQ: SILO) has announced a partnership with Veloxity Labs to conduct GLP-compliant bioanalysis for its SPC-15 intranasal treatment study, aimed at preventing PTSD. This collaboration m...
New York Governor Excludes Controversial Cannabis Smell Provision from State Budget
Governor Kathy Hochul signed New York's latest budget into law, notably excluding a contentious proposal that would have permitted police to consider the smell of cannabis as grounds for suspecting a ...
NRx Pharmaceuticals to Report Q1 2025 Financial Results Following Strategic Acquisition in Psychedelic Research
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) is set to disclose its first quarter 2025 financial outcomes on Thursday, May 15, after the market closes. This announcement will be complemented by a conferenc...
Whoopi Goldberg to Launch Whoop-Tea at Cannabis Means Business 2025
Whoopi Goldberg, an Emmy, Grammy, Oscar, and Tony Award-winning entertainer and entrepreneur, is set to participate in a fireside chat at Cannabis Means Business (CMB) 2025, where she will also launch...
Cybin CEO to Share Insights on Psychedelic Therapeutics at Global Healthcare Showcase
Cybin Inc. (NYSE American: CYBN) (NEO: CYBN), a clinical-stage biopharmaceutical company, announced that its CEO Doug Drysdale will engage in a fireside chat at the virtual Alliance Global Partners He...
Trump Withdraws Nomination of Ed Martin, Impacting Cannabis Industry
The recent decision by President Donald Trump to withdraw the nomination of Ed Martin for the position of U.S. attorney for Washington, D.C., has been met with relief by the broader marijuana industry...
RAW® Rolling Papers Achieves 300 Million+ Organic Views on Meta Platforms in April 2025
20-Year-Old Brand Organically Shatters Social Media Expectations; Solidifies Position as One of The Most Influential Brands in the Industry
Pennsylvania Moves Closer to State-Oversee Cannabis Sales
The Pennsylvania State House has taken a significant step toward legalizing state-overseen cannabis sales, with House Democrats narrowly approving the measure in the Health Committee by a 14-12 vote. ...
Cannabis Means Business Expo Unveils Speaker Lineup and Highlights New York's Market Potential
The Cannabis Means Business (CMB) Expo, a leading business-to-business conference in the cannabis industry, has recently disclosed additional details about its upcoming event, including a distinguishe...
New Research Highlights Risks of Cannabis Use During Pregnancy
Recent findings from a large-scale review of studies have brought to light the potential dangers of using cannabis during pregnancy. The research establishes a connection between prenatal cannabis use...
Canadian Study Highlights Risks and Opportunities in Cannabis Use Among Young Adults
A recent Canadian study has provided valuable insights into the behaviors and personal characteristics associated with higher risks of marijuana-related problems among young adults. This research come...
Cybin Secures U.S. Patent for CYB003 Program, Advancing Psychedelic-Based Treatment for Major Depressive Disorder
Cybin Inc., a clinical-stage neuropsychiatry company, has announced the issuance of U.S. patent 12,291,499 for its CYB003 program, targeting major depressive disorder (MDD). This patent covers pharmac...
Love Yer Brain and MoreBetter Launch Pioneering Study on THC-Infused Beverages
Love Yer Brain (Wayne Coyne) via Iconic Tonics joins MoreBetter for a pioneering study. 2,000 consumers will provide real-world data on hemp-THC beverage impact on mood, quality of life, and alcohol u...
Navigating Advertising Challenges in the Cannabis Industry
The cannabis industry encounters significant challenges in advertising, unlike any other sector, due to a complex web of regulations that restrict how businesses can promote their products. These limi...
Federal Scrutiny on D.C.'s Cannabis Laws Sparks Industry Concern
Washington, D.C.'s cannabis industry is under scrutiny as recent federal moves question the city's handling of marijuana laws, causing unease among major players such as Curaleaf Holdings Inc. (Cboe C...
New Nonprofit 7-HOPE Alliance Launches to Advocate for 7-OHM Access and Research
The launch of the 7-HOPE Alliance represents a significant step forward in the advocacy for 7-hydroxymitragynine (7-OHM), a compound derived from kratom that has shown promise as a safer alternative t...
Cannadelic Miami 2025 Conference to Explore Emerging Therapies and Plant-Based Medicine
The NECANN Cannadelic Miami 2025 conference scheduled for May 23-24, 2025 at the Miami Airport Convention Center represents a significant gathering for professionals and enthusiasts in the cannabis an...